Featured Research

from universities, journals, and other organizations

New Bacteria Target Cancers In Mice

Date:
December 5, 2001
Source:
Johns Hopkins Medical Institutions
Summary:
Scientists from the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins have created bacteria that selectively target large advanced tumors in mice. Results of their experiments are reported in the November 27, 2001 issue of the Proceedings of the National Academy of Sciences.

Scientists from the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins have created bacteria that selectively target large advanced tumors in mice. Results of their experiments are reported in the November 27, 2001 issue of the Proceedings of the National Academy of Sciences.

The scientists found a way to exploit a special germ’s taste for oxygen-starved environments and direct them to target pockets of dead and dying cells within large tumors. These advanced tumors generally have areas of poor blood circulation and thus little oxygen. The lack of oxygen renders them relatively resistant to conventional chemotherapy and radiation but open to bacteria that can grow without oxygen.

“The idea is to selectively attack these tumors from inside with the bacteria and from the outside with chemotherapy,” says Bert Vogelstein, M.D., Clayton Professor of Oncology and Investigator, Howard Hughes Medical Institute.

The scientists systematically screened numerous bacterial species to find one that would thrive in an oxygen-poor environment and, at the same time, destroy surrounding tumor cells. They settled on one spore-forming bacterial species, called Clostridium novyi (C.novyi). C.novyi is normally found in soil and dust and contains a toxin that can cause lethal side effects in animals. They genetically modified the bacteria to remove the toxin gene to make them harmless to normal animals. Then, they injected spores of these bacteria and conventional chemotherapeutic agents into mice with large tumors composed of transplanted human colon cancer cells.

The results achieved with this strategy, called COBALT for combination bacteriolytic therapy were dramatic. More than half of the tumors treated, including very large tumors, were completely destroyed within 24 hours. The tumors decomposed and turned into blackened scars, while the surrounding healthy tissues remained intact. The tumor scars then gradually disappeared over the next two weeks, leaving healthy tissue behind.

Clinical trials are not planned at this time as it will take several years to determine which chemotherapy agents make the best combinations and to develop strategies to avoid the toxicity associated with rapid destruction of large tumor masses. “We hope that this research will add a new dimension to cancer treatment, but realize that the way tumors respond to treatment in mice can be different than in humans,” says Kenneth Kinzler, Ph.D., professor of oncology.

Funding for this research was provided by the Miracle Foundation, the National Colorectal Cancer Research Alliance, the Clayton Fund, and the National Institutes of Health.

In addition to Vogelstein and Kinzler, participants of this research include Long H. Dang, Chetan Bettegowda, and David L. Huso from the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.


Story Source:

The above story is based on materials provided by Johns Hopkins Medical Institutions. Note: Materials may be edited for content and length.


Cite This Page:

Johns Hopkins Medical Institutions. "New Bacteria Target Cancers In Mice." ScienceDaily. ScienceDaily, 5 December 2001. <www.sciencedaily.com/releases/2001/11/011127004139.htm>.
Johns Hopkins Medical Institutions. (2001, December 5). New Bacteria Target Cancers In Mice. ScienceDaily. Retrieved October 22, 2014 from www.sciencedaily.com/releases/2001/11/011127004139.htm
Johns Hopkins Medical Institutions. "New Bacteria Target Cancers In Mice." ScienceDaily. www.sciencedaily.com/releases/2001/11/011127004139.htm (accessed October 22, 2014).

Share This



More Health & Medicine News

Wednesday, October 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Orthodontist Mom Jennifer Salzer on the Best Time for Braces

Orthodontist Mom Jennifer Salzer on the Best Time for Braces

Working Mother (Oct. 22, 2014) Is your child ready? Video provided by Working Mother
Powered by NewsLook.com
U.S. Issues Ebola Travel Restrictions, Are Visa Bans Next?

U.S. Issues Ebola Travel Restrictions, Are Visa Bans Next?

Newsy (Oct. 22, 2014) Now that the U.S. is restricting travel from West Africa, some are dropping questions about a travel ban and instead asking about visa bans. Video provided by Newsy
Powered by NewsLook.com
US to Track Everyone Coming from Ebola Nations

US to Track Everyone Coming from Ebola Nations

AP (Oct. 22, 2014) Stepping up their vigilance against Ebola, federal authorities said Wednesday that everyone traveling into the US from Ebola-stricken nations will be monitored for symptoms for 21 days. (Oct. 22) Video provided by AP
Powered by NewsLook.com
Doctors Help Paralysed Man Walk Again, Patient in Disbelief

Doctors Help Paralysed Man Walk Again, Patient in Disbelief

AFP (Oct. 22, 2014) Polish doctors describe how they helped a paralysed man walk again, with the patient in disbelief at the return of sensation to his legs. Duration: 1:04 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins